Teleflex Files 8-K on Financial Results and Operations

Ticker: TFX · Form: 8-K · Filed: Feb 22, 2024 · CIK: 96943

Teleflex Inc 8-K Filing Summary
FieldDetail
CompanyTeleflex Inc (TFX)
Form Type8-K
Filed DateFeb 22, 2024
Risk Levellow
Pages4
Reading Time4 min
Key Dollar Amounts$1
Sentimentneutral

Sentiment: neutral

Topics: financial-results, regulation-fd, corporate-filing

TL;DR

**Teleflex just dropped an 8-K on their financial results, so keep an eye on their performance!**

AI Summary

Teleflex Incorporated filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition. The filing also included a Regulation FD Disclosure and information on financial statements and exhibits. The company, based in Wayne, PA, operates under the SIC code 3841 for Surgical & Medical Instruments & Apparatus.

Why It Matters

This filing provides an update on Teleflex's financial health and operational performance, which is crucial for investors to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results and operations, not indicating any immediate high-risk events.

Key Players & Entities

  • TELEFLEX INCORPORATED (company) — Registrant
  • February 22, 2024 (date) — Date of Report
  • Delaware (company) — State of Incorporation
  • 550 E. Swedesford Rd., Suite 400 Wayne, PA 19087 (company) — Principal Executive Offices
  • (610) 225-6800 (company) — Registrant's Telephone Number

FAQ

What was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 22, 2024.

What is the full name of the registrant as specified in its charter?

The exact name of the registrant as specified in its charter is TELEFLEX INCORPORATED.

Where are Teleflex Incorporated's principal executive offices located?

Teleflex Incorporated's principal executive offices are located at 550 E. Swedesford Rd., Suite 400, Wayne, PA 19087.

What is the Commission File Number for Teleflex Incorporated?

The Commission File Number for Teleflex Incorporated is 1-5353.

What items of information were included in this 8-K filing?

The 8-K filing included information on Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.

Filing Stats: 1,110 words · 4 min read · ~4 pages · Grade level 14.3 · Accepted 2024-02-22 07:00:33

Key Financial Figures

  • $1 — ich registered Common Stock, par value $1 per share TFX New York Stock Exchange

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On February 22, 2024, Teleflex Incorporated (the "Company") issued a press release (the "Press Release") announcing its financial results for the quarter and year ended December 31, 2023. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report. In addition to the financial information included in the Press Release that has been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), the Press Release includes certain non-GAAP financial measures. These measures include constant currency revenue growth and adjusted diluted earnings per share. Constant currency revenue growth is based upon net revenues, adjusted to eliminate the impact of translating the results of international subsidiaries at different currency exchange rates from period to period. The impact of changes in foreign currency may vary significantly from period to period, and generally are outside of the control of our management. We believe that this measure facilitates a comparison of our operating performance exclusive of fluctuations that do not reflect our underlying performance or business trends. Adjusted diluted earnings per share is based upon diluted earnings per share available to common stockholders, the most directly comparable GAAP measure, adjusted to exclude, depending on the period presented, the impact (net of tax) of (i) restructuring, restructuring related and impairment items; (ii) acquisition, integration and divestiture related items; (iii) other items identified in the reconciliation tables set forth in the Press Release, as applicable; (iv) costs incurred in connection with our implementation of a new global enterprise resource planning system and related information technology transition costs; (v) pension termination and related charges; (vi) certain expenditures associated with the registration of medical devices under the European Union Medical Devic

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. In connection with the conference call to be held by the Company on February 22, 2024 to discuss its financial results for the quarter and year ended December 31, 2023, the Company plans to reference a slide presentation, which will be made available in advance of the call through the Company's website. A copy of the slide presentation is furnished as Exhibit 99.2 to this Current Report. The information furnished pursuant to Item 7.01 of this Current Report, including Exhibit 99.2, shall not be considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended or under the Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to be considered "filed" or incorporated by reference therein.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. 99.1 Earnings Press Release, dated February 2 2, 202 4 99.2 Earnings Conference Call Slide Presentation 104 The Cover Page from this Current Report on Form 8-K, formatted in Inline XBRL Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 22, 2024 TELEFLEX INCORPORATED By: /s/ Thomas E. Powell Name: Thomas E. Powell Title: Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.